1. Home
  2. Live Updates
  3. Agomab Therapeutics NV: Agomab Starts Phase 1 Clinical Study

Agomab Therapeutics NV: Agomab Starts Phase 1 Clinical Study

Agomab Therapeutics NV: Agomab Starts Phase 1 Clinical Study for AGMB-447 in Healthy Subjects and Patients with Idiopathic Pulmonary Fibrosis

Agomab Therapeutics NV: Agomab Starts Phase 1 Clinical Study for AGMB-447 in Healthy Subjects and Patients with Idiopathic Pulmonary Fibrosis

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

, Tim Knotnerus , Gretchen Schweitzer , Stefan Klotter , Trophic Communications , Single Ascending Dose , Multiple Ascending Dose , Chief Development Officer , Idiopathic Pulmonary Fibrosis , Fibrostenosing Crohn , Idiopathic Pulmonary , Transforming Growth Factor , Hepatocyte Growth Factor , Agomab Therapeutics , Stephanie May , Lassen Sie ,